Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening

Guidelines for colorectal cancer screening and surveillance.

Continue NCCN . org NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines TM ) Rectal Cancer

Colorectal cancer. Summary of Canadian screening guidelines.

T full version of the Canadian colorectal cancer screening guidelines has been published in the Canadian Journal of Gastroenterology.1 The guidelines were prepared collaboratively by the Canadian Association of Gastroenterology (CAG), the Canadian Digestive Health Foundation (CDHF), and the Canadian Society of Primary Care Gastroenterology (CanGut). The technical report of Health Canada’s Natio...

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Myelodysplastic Syndromes

NCCN All recommendations are category 2A unless otherwise specified. See believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged. NCCN To find clinical trials online at NCCN Member Institutions, click here: nccn.org/clinical_trials/physician.html. The NCCN Guidelines are a statement of evidence and consensus of t...

Updated Canadian colorectal cancer screening guidelines.

www.thelancet.com/oncology Published online February 25, 2016 http://dx.doi.org/10.1016/S1470-2045(16)00139-X 1 Updated Canadian guidelines recommend that low-risk adults aged 50 to 74 years should be screened for colorectal cancer with faecal occult blood testing (FOBT) or faecal immunochemical testing (FIT) every 2 years, or fl exible sigmoidoscopy every 10 years, rather than colonoscopy. The...